Clinical Trials Browser

Phase NA × Nivolumab × Dermatologic × Clear all

NCT07436390 2026-03-02

MAK

Phase NA Completed

Melanoma, Skin Neoplasms

NCT07422779 2026-02-20

MAK

Phase NA Recruiting

Melanoma, Skin Neoplasms

NCT05652673 2025-02-28

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Phase NA Recruiting

Melanoma, Drug-Related Side Effects and Adverse Reactions